Evidence map›Paper›PMID 36962540›Full record

ArticlePLOS global public health2022

COVID-19 vaccine hesitancy and its determinants among sub-Saharan African adolescents.

Dongqing Wang, Angela Chukwu, Mary Mwanyika-Sando, Sulemana Watara Abubakari, Nega Assefa, Isabel Madzorera, Elena C Hemler, Abbas Ismail, Bruno Lankoande, Frank Mapendo and 17 more

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Global Systematic Scoping Review of Adolescent Factors Associated With COVID-19 Vaccine Hesitancy.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 13 institutions in 8 countries.

Dongqing WangDepartment of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia, United States of America.ORCID https://orcid.org/0000-0003-3369-5972
Angela ChukwuDepartment of Statistics, University of Ibadan, Ibadan, Nigeria.
Mary Mwanyika-SandoAfrica Academy for Public Health, Dar es Salaam, Tanzania.
Sulemana Watara AbubakariKintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo North Municipality, Bono East Region, Ghana.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID https://orcid.org/0000-0003-0341-2329
Isabel MadzoreraDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Elena C HemlerDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Abbas IsmailCollege of Natural and Mathematical Sciences, University of Dodoma, Dodoma, Tanzania.
Bruno LankoandeInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Frank MapendoAfrica Academy for Public Health, Dar es Salaam, Tanzania.
Ourohiré MillogoNouna Health Research Center, Nouna, Burkina Faso.ORCID https://orcid.org/0000-0002-2552-8122
Firehiwot WorknehAddis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Temesgen AzemrawAddis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Lawrence Gyabaa FebirKintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo North Municipality, Bono East Region, Ghana.
Christabel JamesUniversity of Ibadan Research Foundation, University of Ibadan, Ibadan, Nigeria.ORCID https://orcid.org/0000-0001-5279-594X
Amani TinkasimileAfrica Academy for Public Health, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0002-9401-0060
Kwaku Poku AsanteKintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo North Municipality, Bono East Region, Ghana.ORCID https://orcid.org/0000-0001-9158-351X
Till BaernighausenDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Yemane BerhaneAddis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Japhet KillewoDepartment of Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ayoade M J OduolaUniversity of Ibadan Research Foundation, University of Ibadan, Ibadan, Nigeria.
Ali SieNouna Health Research Center, Nouna, Burkina Faso.
Emily R SmithDepartment of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, United States of America.
Abdramane Bassiahi SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Tajudeen RajiDivision of Public Health Institutes and Research, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0001-9849-5088
Said VuaiCollege of Natural and Mathematical Sciences, University of Dodoma, Dodoma, Tanzania.
Wafaie W FawziDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Harvard University · USAddis Continental Institute of Public Health · ETAfrica Academy for Public Health · TZKintampo Health Research Centre · GHUniversity of Ibadan · NGCentre de Recherche en Santé de Nouna · BFThe University of Dodoma · TZUniversité Joseph Ki-Zerbo · BFAfrica Centres for Disease Control and Prevention · ETGeorge Mason University · USHaramaya University · ETMilken Institute · USMuhimbili University of Health and Allied Sciences · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 vaccine hesitancy among adolescents poses a challenge to the global effort to control the pandemic. This multi-country survey aimed to assess the prevalence and determinants of COVID-19 vaccine hesitancy among adolescents in sub-Saharan Africa between July and December 2021. The survey was conducted using computer-assisted telephone interviewing among adolescents in five sub-Saharan African countries, Burkina Faso, Ethiopia, Ghana, Nigeria, and Tanzania. A rural area and an urban area were included in each country (except Ghana, which only had a rural area), with approximately 300 adolescents in each area and 2662 in total. Sociodemographic characteristics and perceptions and attitudes on COVID-19 vaccines were measured. Vaccine hesitancy was defined as definitely not getting vaccinated or being undecided on whether to get vaccinated if a COVID-19 vaccine were available. Log-binomial models were used to calculate the adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for associations between potential determinants and COVID-19 vaccine hesitancy. The percentage of COVID-19 vaccine hesitancy was 14% in rural Kersa, 23% in rural Ibadan, 31% in rural Nouna, 32% in urban Ouagadougou, 37% in urban Addis Ababa, 48% in rural Kintampo, 65% in urban Lagos, 76% in urban Dar es Salaam, and 88% in rural Dodoma. Perceived low necessity, concerns about vaccine safety, and concerns about vaccine effectiveness were the leading reasons for hesitancy. Healthcare workers, parents or family members, and schoolteachers had the greatest impacts on vaccine willingness. Perceived lack of safety (aPR: 3.52; 95% CI: 3.00, 4.13) and lack of effectiveness (aPR: 3.46; 95% CI: 2.97, 4.03) were associated with greater vaccine hesitancy. The prevalence of COVID-19 vaccine hesitancy among adolescents is alarmingly high across the five sub-Saharan African countries, especially in Tanzania. COVID-19 vaccination campaigns among sub-Saharan African adolescents should address their concerns and misconceptions about vaccine safety and effectiveness.

Identifiers

PMID36962540
PMCPMC10022111
OpenAlexW4302013589

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read121
identifiers read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.